Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Both steroids effectively promote hair growth for at least 9 months.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Hair transplant for eyebrow alopecia areata provided significant relief and improved treatment response.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.